Reason reports back from Rejuvenation Startup Summit 2024
Fight Aging! - 13-May-2024A great summary of 25 speakers who are in various stages of platform building, drug discovery and clinical trials
Louis Hawthorne
Founder and CEO at NaNotics
Lou is an innovator with 25 years of experience in biotech/life science development, artificial intelligence, venture equity, and branding/media design. Lou received a B.A. in English Literature in 1983 from Princeton University, where he was a University Scholar, ran the Film Society and received the Ward Mathis prize.
Lou is a passionate science and technology entrepreneur, with dozens of patents and patents pending. He is the CEO of NaNotics, LLC, which is developing a new nano-medical platform called "NaNots" – which are immune modulating nano-scavengers, which Lou invented and patented. NaNotics has raised a $8.75m to date and is currently building NaNots against cancer, sepsis, autoimmune disease and aging.
Before founding NaNotics, Lou worked for over 10 years with Dr. John Sperling, founder of the University of Phoenix, leading various scientific companies & projects on Sperling’s behalf, including development of commercial cloning capabilities for cat, dog and other species. Lou also served on Sperling's "Greenlight Committee", reviewing $1b in equity investment proposals and approving over $100m, primarily for longevity and oncology research.
Visit website: http://www.nanotics.com/team/lou-hawthorne/
See also
NaNotics
Company developing a novel nano-medicine platform for treating multiple diseases, including cancer, sepsis, auto-immune disorders and the harmful effects of aging.
Details last updated 23-Apr-2020
Louis Hawthorne News
Reason reports back from Age-Related Disease Therapeutics Summit 2023
Fight Aging! - 16-Jun-2023Many people believe lots of clinical trials of novel therapeutics targeting mechanisms of aging will start up in the next few years
Lifespan.io interviews NaNotics' CEO Lou Hawthorne to find out more about Nanots
Lifespan.io (LEAF) - 04-Nov-2022Many conditions could be improved by removing signalling that prevents cells operating at their best
Reason reports back from October's Rejuvenation Startup Summit
Fight Aging! - 19-Oct-2022Some really exciting developments with quite a few in clinical trials
Mayo Clinic is excited to collaborate with NaNotics for cancer treatment
Business Wire - 04-Jan-2022Ultra-low toxicity NaNots could have a wide variety of applications
Display all news
Louis Hawthorne is also referenced in the following:
Age-Related Disease Therapeutics Summit
31-May-2023 to 02-Jun-2023
Event about aging and aging related diseases organized by Hanson Wade
D.C. Summit 2025
28-Apr-2025
The Second Annual Alliance for Longevity Initiatives summit (Washington, D.C., USA)
Longevity Summit Dublin 2023
17-Aug-2023 to 20-Aug-2023
Club discount available - click here
Event gathering Global Longevity and Rejuvenation community in Dublin with many longevity movement superstars as speakers
Longevity Summit Dublin 2024
13-Jun-2024 to 16-Jun-2024
Event gathering Global Longevity and Rejuvenation community in Dublin by LEV Foundation (Dublin, Ireland)
Lou Hawthorne at ARDD2024: NaNots: A Novel Platform for Adsorbing Soluble ... Diseases & Aging
Lou Hawthorne unveils a platform to adsorb disease and aging drivers
Rejuvenation Startup Summit 2024
10-May-2024 to 11-May-2024
The leading networking event for rejuvenation startups, longevity investors and translational researchers by Forever Healthy Foundation
Uncloaking Cancer by Depleting Circulating Factors - Lou Hawthorne at Longevity Summit Dublin 2024
Lou Hawthorne delivered a keynote on uncloaking cancer by depleting circulating factors
Louis Hawthorne Blog Posts
24-Aug-2023
Highlights from Longevity Summit Dublin 2023
Key points and slides from the leading longevity conference hosted by Aubrey de Grey
